Neal Goodwin, PhD
Chief Scientific Officer, Jaya Biosciences, Inc.
Neal Goodwin serves as our Chief Scientific Officer responsible for all Jaya research and development programs. Neal recently served as CSO for Teknova (NASDAQ: TKNO), where he implemented gene delivery technology platforms. Prior to Teknova, he was Vice President of Corporate Research Development for Champions Oncology (NASDAQ: CSBR), where his responsibilities included the development of a pharmacology platform portfolio for personalized and translational oncology. Prior to Champions, he served as the Director of Research and Development and the founding Program Director of JAX Cancer Services, where he established an oncology translational tumor biology program in collaboration with over 20 clinical trial centers. Dr. Goodwin is a co-founder and former CSO of ProNAi Therapeutics (Sierra Oncology; NASDAQ: SRRA; acquired by GSK). Dr. Goodwin received a Ph.D. in Microbiology from The University of Montana and served an NIH postdoctoral fellowship in functional genomics at The Jackson Laboratory with John Schimenti (now at Cornell). https://www.linkedin.com/in/neal-goodwin-phd-mba-0612909/